[{"Assets_0_FY_USD":703588000.0,"CIK":"1743881","CommonStockSharesConverted_0_FY_shares":125264070.0,"CommonStockSharesOutstanding_0_FY_shares":122849389.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":-3.8,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-399714000.0,"NetIncomeLossConverted_4_FY_USD":-448724000.0,"OfficialName":"BridgeBio Pharma Inc. Common Stock","RevenuesConverted_4_FY_USD":8249000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":106256000.0,"StockholdersEquity_0_FY_USD":57906000.0,"Ticker":"BBIO","filed":"20210225","footnote":"nan","form":"10-K","fp":"FY","fy":"2020.0","name":"BRIDGEBIO PHARMA, INC.","period":"20201231","qtrs":"0","uom":"USD"}]